Scalable throughput from microliters to liters
NanoGenerator® Synthesis System
Nanoparticle Formulation & Preparation
NanoGenerator® is a high-performance nanoparticle synthesis system for formulation and preparation of nanoparticles, including lipid nanoparticles (LNPs), liposomes, PLGA, etc. Lipid nanoparticle synthesis is the process of creating lipid nanoparticles, a type of drug delivery system that encapsulates therapeutic molecules in a lipid shell. LNP synthesis plays a crucial role in drug delivery and therapeutics.
NanoGenerator produces nanoparticles with improved size uniformity and lower polydispersity index (PDI). It offers scalable production, ranging from ultra-low volumes of 0.1 mL for early-stage screening to large-scale batch production of hundreds of liters, enabling seamless, continuous GMP-compliant manufacturing.
Path from Discovery to Commercialization
The NanoGenerator system offers controllable and reproducible mixing conditions, ensuring the accurate synthesis of LNPs through its scalable architecture found in the entire NanoGenerator product line.
This architecture facilitates the seamless transfer of crucial process parameters, guaranteeing consistent critical quality attributes (CQAs) as one transitions from discovery and screening and process development to GMP production and commercial manufacturing.
NanoGenerator Models
Discovery & Screening
Pre-Clinical
Clinical & Commercialization
System Benefits
High Performance & Efficiency
-
Tunable size (40-200nm)
-
Low PDI
-
High encapsulation efficiency
Automation & QC
-
Automated workflow
-
Real-time data monitoring & recording
Open Platform
-
LNP reagents
-
Microfluidic mixer chips
Cost Effective
-
Affordable system
-
Low cost consumables
-
Minimum maintenance
Scalable & Reproducible
-
Scale-up and minimum process development
-
Direct transfer from clinical development to commercial manufacturing
-
Reproducible manufacturing
Custom Design & Service
-
Custom design & OEM
-
Research collaboration
-
On-site 3Q installation & qualification (optional)
Cost-effective, Scalable and Reproducible
Discovery & Screening
PreciGenome's NanoGenerator 's precise parameter control ensures consistent critical quality attributes throughout the entire development and manufacturing process. This guarantees speed, cost-effectiveness, and reliability at every stage.
Working Principle
Payloads
There are a variety of types of LNP payloads, each with specific advantages and capable of treating different types of diseases. Genetic medicines include DNA and RNA, both of which serve as therapeutic agents when delivered into the body. These genetic materials act as versatile payloads with good scalability. Moreover, they’ve undergone clinical validation to demonstrate their safety. Other major payload types include proteins and small molecules.
mRNA/siRNA
Proteins and peptides
DNA
Small molecules
Carriers
Utilizing NanoGenerator technology, users may develop a diverse array of nanoparticle formulations, each varying in size, payload, and excipient characteristics.
Payloads
Carrier Materials
-
Nucleic Acid
-
Peptides and Proteins
-
Ionizable lipids/Cationic lipids
-
Phospholipids
-
Cholesterol
-
PEG-Lipids
-
Nucleic Acid
-
Peptides and Proteins
-
Small Molecules
-
Imaging Contrast Agents
-
Phospholipids
-
Cholesterol
-
PEG-Lipids
Polymer Nanoparticles
-
Nucleic Acid
-
Peptides and Proteins
-
Small Molecules
-
Imaging Contrast Agents
-
Poly-lactides (such as PLGA)
-
Block copolymers (such as PEG-b-PLGA)
-
Polysaccharides (such as chitosan, cellulose)
Emulsions
-
Small Molecules
-
Imaging Contrast Agents
-
Triolein/POPC
-
Oil
-
Surfactant
Exosomes
-
Nucleic Acid
-
Peptides and Proteins
-
Small Molecules
-
Natural cell-derived lipids
-
Natural cell-derived proteins
-
Additional synthetic lipids
-
Additional synthetic biomolecules
System Applications
Gene Therapy
Genetic drugs, including small interfering RNA (siRNA), mRNA, and plasmid DNA, hold promise for treating a wide array of diseases by either suppressing harmful genes, producing therapeutic proteins, or employing gene-editing techniques. Currently, LNP systems stand at the forefront among non-viral delivery methods, enabling the clinical utilization of genetic drugs.
Vaccines
Lipid nanoparticles have played a pivotal role in expediting the development of vaccines, as demonstrated by Pfizer and Moderna in the COVID-19 pandemic response. It allows for precise and high-throughput screening of potential vaccine candidates. The technology facilitates rapid testing, antigen formulation, and optimization of vaccine delivery systems.
Cell Therapy
Cell therapy entails the transformation of cells, commonly immune cells, obtained from either the patient (autologous) or a compatible donor (allogeneic). These modified cells undergo isolation and amplification. They are then reintroduced into the patient. Lipid nanoparticles present a versatile approach to cell reprogramming, facilitating the transfer of RNA responsible for protein expression or gene editing.
(Lean more gene editing)
Other Areas
